Nachrichten zur Hims & Hers Health Aktie

HIMS Stock Surges after Court Case with Eli Lilly Gets Put on Hold

Shares of healthcare company Hims Hers Health ($HIMS) surged on Thursday after a Texas court temporarily paused a case…

Hims & Hers Health Expands Board with New Appointment

Hims & Hers Health ( ($HIMS) ) has provided an update. Hims & Hers Health, Inc. has expanded its board…

Hims & Hers closes up 10% as Lilly tirzepatide compounding dispute resolution delayed

HIM & Hers Health stock rises after federal court closes case on FDAs GLP-1 tirzepatide shortage determination. Read more here.…

FDA tirzepatide status report ‘moderately positive’ for Hims & Hers, says Citi

Citi notes that the FDA said in a status report filed in a Texas court that it needs more time…

Hims & Hers jumps as status report says patients unable to obtain branded GLP-1s

A joint status report that was filed in the U.S. District Court for the Northern District of Texas states in…

Hims & Hers announces daily meal replacement bars and shakes

Hims Hers Health (HIMS) announced that Hims Hers customers will now be able to supplement their treatment plan…

Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys

SAN FRANCISCO, November 21, 2024--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform,…

Hims & Hers Launches Premium Weight Loss Subscription with Protein-Rich Meal Replacements

Hims & Hers Health expands weight management offerings with new protein bars and shakes subscription program, starting at $110/month. Includes…

January 2025 Options Now Available For Hims & Hers Health (HIMS)

Investors in Hims & Hers Health Inc (Symbol: HIMS) saw new options become available today, for the January 2025 expiration.…

Principal Financial Group Inc. Has $5.35 Million Holdings in Hims & Hers Health, Inc. (NYSE:HIMS)

Principal Financial Group Inc. boosted its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report)…

Hims & Hers Health, Inc. (NYSE:HIMS) Receives Average Recommendation of "Hold" from Brokerages

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) has been assigned an average rating of "Hold" from the…

Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that Hims…

Hims & Hers Health: Far From Dead, Even With Amazons Threat Ahead (NYSE:HIMS)

Hims & Hers financials are robust, with strong and accelerating revenue growth, growing free cash flow, manageable SBC, and no…

Hims & Hers Health: Far From Dead, Even With Amazons Threat Ahead

…

TD Cowen reaffirms Buy rating on Hims and Hers stock, highlights FDA case impact By Investing.com

TD Cowen reaffirms Buy rating on Hims and Hers stock, highlights FDA case impact…

Connor Clark & Lunn Investment Management Ltd. Lowers Holdings in Hims & Hers Health, Inc. (NYSE:HIMS)

Connor Clark & Lunn Investment Management Ltd. lessened its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS…

Hims & Hers Health (NYSE:HIMS) Shares Gap Down

Hims & Hers Health (NYSE:HIMS) Shares Gap Down - Whats Next?…

Hims & Hers Health Inc (HIMS) Trading 8.64% Higher on Nov 19

Shares of Hims & Hers Health Inc (HIMS) surged 8.64% in mid-day trading on Nov 19. The stock reached an…

Hims & Hers Stock Climbs After Former Regulator Autor Joins Board

By Dean Seal Shares of Hims & Hers Health jumped after the company added former Food and Drug Administration official…

Darum habe ich bei Hims & Hers nachgekauft

Hims & Hers ist für mich die überzeugendste Kaufgelegenheit in einem sonst teuren Marktumfeld. Amazons "neues” Konkurrenzangebot verdeutlicht erneut, dass…

Hims & Hers names Deb Autor to board, Janet Stevens as head of quality, safety

Hims Hers Health, announced Deb Autor, former deputy commissioner at the FDA, will join the company’s board of directors,…

Hims & Hers Bolsters Leadership with Former FDA Commissioner, Quality Expert

Hims & Hers Health strengthens clinical excellence with two strategic appointments: former FDA deputy commissioner Deb Autor joins board, while…

Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions

Former FDA deputy commissioner and former Pfizer & Hillrom quality executive join Hims & Hers, deepening the leadership that drives…

Hims & Hers Health, Inc. (NYSE:HIMS) Shares Purchased by Royce & Associates LP

Royce & Associates LP raised its stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 17.0%…

Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions

Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor,…

Hims & Hers Health, Inc. (HIMS): A Bull Case Theory

We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by The Dutch Investors. In this article,…

Hims & Hers Health, Inc. (HIMS): A Bull Case Theory

We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by The Dutch Investors. In…

Hims & Hers Stock Is Down 30% This Week: Heres What Happened

Shares of Hims & Hers (NYSE: HIMS) is down big this week after Amazon (NASDAQ: AMZN) announced its expansion into…

Hims & Hers Stock Is Down 30% This Week: Heres What Happened

Motley Fool Press Release.…

Hims & Hers Stock Is Down 30% This Week: Heres What Happened

Hims & Hers has given back recent gains, but dont overlook the companys massive growth.…

Hims & Hers Stock Is Down 30% This Week: Heres What Happened @themotleyfool #stocks $HIMS $AMZN $WMT

Hims & Hers has given back recent gains, but dont overlook the companys massive growth.…

Should You Buy Hims & Hers Stock on the Dip?

Hims & Hers (NYSE: HIMS) is disrupting the healthcare market with its innovative patient treatment approach. Stock prices used were…

Should You Buy Hims & Hers Stock on the Dip?

Hims & Hers (NYSE: HIMS) is disrupting the healthcare market with its innovative patient treatment approach.…

Should You Buy Hims & Hers Stock on the Dip?

Hims & Hers (NYSE: HIMS) is disrupting the healthcare market with its innovative patient treatment approach.…

Hims & Hers: Revolutionizing Telehealth And Captivating Investors - Why You Should Buy?

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we recommend a…

Hims & Hers: Revolutionizing Telehealth And Captivating Investors - Heres Why You Should Buy

…

Hims & Hers Health: The Amazon Curse Is Being Overstated (NYSE:HIMS)

Hims & Hers Healths stock dropped 25% due to Amazon’s competition. Learn why HIM stocks 38% upside and strong growth…

Hims & Hers Health: The Amazon Curse Is Being Overstated

…

Health tech Q3 earnings recap—Hims & Hers plans to launch generic GLP-1; Doximity sees fast growth in AI tools

Hims & Hers sees explosive growth with plans to launch generic GLP-1 drugBusiness is booming for online health and wellness…

Amazon One Medical vs. Hims & Hers Health: Bedrohung oder Chance?

Hims & Hers Health (HIMS) erlebte einen Rückschlag, nachdem Amazon (AMZN) eine Anpassung in ihrem One Medical Pay-per-Visit Telemedizin-Programm  ankündigte. Die…

Hims & Hers stock (HIMS) drops 24% after Amazon telehealth announcement—heres why

HIMS stock sees its worst-ever drop as Amazon threatens to undercut its core business…